Pierre Dumouchel’s term as interim chief executive officer has been made permanent, according to a press release from Safe Orthopaedics.
The Board of Directors has decided to confirm his position, following his initial appointment in March 2016.
According to the release, Dumouchel has introduced Safe Orthopaedics’ new strategy of refocusing the company’s activities on its most dynamic regions—France, the rest of Europe and emerging markets.
Under his leadership, Safe Orthopaedics has entered into several new distribution agreements covering Australia and New Zealand, plus Mexico and Chile in Latin America. During his tenure, Safe Orthopaedics’ offering has also been extended and the cervical range launched successfully.
Furthermore, the Board of Directors has decided to appoint Alain Coudray as chairman of the Board of Directors. Alain Coudray was previously a non-voting advisor to the board, before being appointed as a director of Safe Orthopaedics on March 1, 2016. On June 1, 2016, he left his executive duties as vice-president of Global Corporate Clinical Affairs at Medtronic. However, he continues to collaborate with Medtronic.
Alain Coudray is replacing Gérard Vaillant, who has decided to retire after having launched the commercial and international development of Safe Orthopaedics’ products.
Gérard Vaillant says: “After forty years in executive roles in the medical devices industry, including three with Safe Orthopaedics, it is a privilege for me to be handing over to Alain Coudray.”
Coudray adds, “Given the success achieved by Pierre Dumouchel in just a few months, it was an obvious decision for the Board of Directors to make his appointment permanent.”
